These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21113737)

  • 1. Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency.
    Tabatabaie L; Klomp LW; Rubio-Gozalbo ME; Spaapen LJ; Haagen AA; Dorland L; de Koning TJ
    J Inherit Metab Dis; 2011 Feb; 34(1):181-4. PubMed ID: 21113737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infantile Serine Biosynthesis Defect Due to Phosphoglycerate Dehydrogenase Deficiency: Variability in Phenotype and Treatment Response, Novel Mutations, and Diagnostic Challenges.
    Benke PJ; Hidalgo RJ; Braffman BH; Jans J; Gassen KLIV; Sunbul R; El-Hattab AW
    J Child Neurol; 2017 May; 32(6):543-549. PubMed ID: 28135894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Phosphoglycerate dehydrogenase deficiency: description of two new cases in Tunisia and review of the literature.
    Kraoua I; Wiame E; Kraoua L; Nasrallah F; Benrhouma H; Rouissi A; Turki I; Chaabouni H; Briand G; Kaabachi N; Van Schaftingen E; Gouider-Khouja N
    Neuropediatrics; 2013 Oct; 44(5):281-5. PubMed ID: 23564319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-phosphoglycerate dehydrogenase deficiency: a case report of a treatable cause of seizures.
    Coşkun T; Aydin HI; Kiliç M; Dursun A; Haliloğlu G; Topaloğlu H; Karli-Oğuz K; de Koning TJ
    Turk J Pediatr; 2009; 51(6):587-92. PubMed ID: 20196394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency.
    de Koning TJ; Duran M; Dorland L; Gooskens R; Van Schaftingen E; Jaeken J; Blau N; Berger R; Poll-The BT
    Ann Neurol; 1998 Aug; 44(2):261-5. PubMed ID: 9708551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency.
    de Koning TJ; Jaeken J; Pineda M; Van Maldergem L; Poll-The BT; van der Knaap MS
    Neuropediatrics; 2000 Dec; 31(6):287-92. PubMed ID: 11508546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new cases of serine deficiency disorders treated with l-serine.
    Brassier A; Valayannopoulos V; Bahi-Buisson N; Wiame E; Hubert L; Boddaert N; Kaminska A; Habarou F; Desguerre I; Van Schaftingen E; Ottolenghi C; de Lonlay P
    Eur J Paediatr Neurol; 2016 Jan; 20(1):53-60. PubMed ID: 26610677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with amino acids in serine deficiency disorders.
    de Koning TJ
    J Inherit Metab Dis; 2006; 29(2-3):347-51. PubMed ID: 16763900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency.
    de Koning TJ; Klomp LW; van Oppen AC; Beemer FA; Dorland L; van den Berg I; Berger R
    Lancet; 2004 Dec 18-31; 364(9452):2221-2. PubMed ID: 15610810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild phenotypes of phosphoglycerate dehydrogenase deficiency by a novel mutation of PHGDH gene: Case report and literature review.
    Fu J; Chen L; Su T; Xu S; Liu Y
    Int J Dev Neurosci; 2023 Feb; 83(1):44-52. PubMed ID: 36308023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids.
    De Koning TJ; Duran M; Van Maldergem L; Pineda M; Dorland L; Gooskens R; Jaeken J; Poll-The BT
    J Inherit Metab Dis; 2002 May; 25(2):119-25. PubMed ID: 12118526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on serine deficiency disorders.
    van der Crabben SN; Verhoeven-Duif NM; Brilstra EH; Van Maldergem L; Coskun T; Rubio-Gozalbo E; Berger R; de Koning TJ
    J Inherit Metab Dis; 2013 Jul; 36(4):613-9. PubMed ID: 23463425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of
    Ali A; Dhahouri NA; Almesmari FSA; Fathalla WM; Jasmi FA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34066864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the phenotypic spectrum of serine biosynthesis defects.
    El-Hattab AW; Shaheen R; Hertecant J; Galadari HI; Albaqawi BS; Nabil A; Alkuraya FS
    J Inherit Metab Dis; 2016 May; 39(3):373-381. PubMed ID: 26960553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serine synthesis defect presenting with a Charcot-Marie-Tooth-like polyneuropathy.
    Méneret A; Wiame E; Marelli C; Lenglet T; Van Schaftingen E; Sedel F
    Arch Neurol; 2012 Jul; 69(7):908-11. PubMed ID: 22393170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
    Tabatabaie L; de Koning TJ; Geboers AJ; van den Berg IE; Berger R; Klomp LW
    Hum Mutat; 2009 May; 30(5):749-56. PubMed ID: 19235232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a premature stop codon mutation in the PHGDH gene in severe Neu-Laxova syndrome-evidence for phenotypic variability.
    Mattos EP; Silva AA; Magalhães JA; Leite JC; Leistner-Segal S; Gus-Kessler R; Perez JA; Vedolin LM; Torreblanca-Zanca A; Lapunzina P; Ruiz-Perez VL; Sanseverino MT
    Am J Med Genet A; 2015 Jun; 167(6):1323-9. PubMed ID: 25913727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome.
    Pineda M; Vilaseca MA; Artuch R; Santos S; García González MM; Aracil A; Van Schaftingen E; Jaeken J
    Dev Med Child Neurol; 2000 Sep; 42(9):629-33. PubMed ID: 11034457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling.
    Glinton KE; Benke PJ; Lines MA; Geraghty MT; Chakraborty P; Al-Dirbashi OY; Jiang Y; Kennedy AD; Grotewiel MS; Sutton VR; Elsea SH; El-Hattab AW
    Mol Genet Metab; 2018 Mar; 123(3):309-316. PubMed ID: 29269105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings.
    Häusler MG; Jaeken J; Mönch E; Ramaekers VT
    Neuropediatrics; 2001 Aug; 32(4):191-5. PubMed ID: 11571699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.